Related Experiment Video
Updated: Dec 26, 2025
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Sexual dysfunction in patients with chronic prostatitis and its treatment]
1FGBOU VO Academician Ye. A. Vagner Perm State Medical University of the Ministry of Healthcare of the Russian Federation, Perm, Russia.
Aim:
to study the frequency and type of sexual disorders in patients with chronic prostatitis (CP) and to evaluate the efficiency of Vitaprost and the biologically active complex NeuroDose in treating sexual dysfunctions.
Materials And Methods:
The study was conducted in 2015-2019 and consisted of two stages.
Study Design:
At the first stage, the frequency and type of sexual disorders were evaluated in 422 patients with CP. Standard methods for examining patients with CP included Loran-Segal questionnaire of male copulative function (MCF), International Index of Erectile Function (IIEF-5), ICEF-5, criteria of premature ejaculation, Treatment Satisfaction Visual Analogue Scale of orgasm quality and Hospital Anxiety and Depression Scale (HADS). Patients received standard 6-week complex therapy for CP. After that, at the second stage, 244 patients with sexual dysfunction (premature ejaculation, decreased intensity of orgasm) received Vitaprost and the NeuroDose biocomplex for 2 months.
Results:
Sexual disorders were detected in 77% of patients with CP. The main disorders were premature ejaculation (60.9%) and decreased intensity of orgasm (43.8%), which often occurred simultaneously. Two-month therapy of sexual dysfunction with Vitaprost and NeuroDose was effective in 94.3% of patients. Good results were observed in 80.3% of cases, while satisfactory results were obtained in 14% of patients. According to MCF, total copulative function increased by 46%, the duration of sexual intercourse increased from 1.1+/-0.4 min to 4.1+/-0.4 min (p<0.001) with an absence of premature ejaculation in 81.6% of patients, the intensity of orgasm increased from 3.8+/-0.4 to 8.0+/-0.5 (p<0.001) points, and the number of patients with neuropsychiatric symptoms associated mainly with sexual dysfunction decreased by 69.3%.
Conclusion:
Premature ejaculation and decreased intensity of orgasm are the most common sexual disorders in CP, and the combination of Vitaprost and dietary supplements NeuroDose is highly effective for their treatment.
More Related Videos
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
09:49Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
Published on: August 13, 2015
Related Concept Videos
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:17Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
01:21Nursing Assessment of the Genitourinary System I: Health History
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...